Dovato use could lead to resistance and could exclude switching over to some current HAART treatments. Leronlimab is the only HIV drug that doesn't develop resistance, patients would have to turn to us.

Quote:

---

Strong warning against Dovato 2-drug regimen as first-line therapy by San Francisco HIV expert

---

https://www.sfaf.org/collections/beta/strong-...iv-expert/